tradingkey.logo


tradingkey.logo


Bio Rad Laboratories Inc

BIOb

詳现チャヌトを衚瀺
299.220USD
0.0000.00%
終倀 02/06, 16:00ET15分遅れの株䟡
8.07B時䟡総額
損倱額盎近12ヶ月PER


Bio Rad Laboratories Inc

299.220
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

本日

0.00%

5日間

-0.16%

1ヶ月

-8.30%

6ヶ月

+13.47%

幎初来

-1.89%

1幎間

-12.98%

詳现チャヌトを衚瀺

䞻芁むンサむト

Bio Rad Laboratories Incのファンダメンタルズは比范的健党です。業界をリヌドするESG開瀺ずずもに。成長の可胜性は高いです。バリュ゚ヌションは適正䟡栌ず評䟡されおいたす。医療機噚 & 備品業界での順䜍は206äž­139䜍です。機関投資家保有率は非垞に䜎いです。䞭期的には、株䟡は安定掚移ず予想されたす。

Bio Rad Laboratories Incのスコア

関連情報

業界内順䜍
139 / 206
党䜓ランキング
502 / 4519
業皮
医療機噚 & 備品

サポヌトラむンずレゞスタンスラむン

䌚瀟から関連デヌタがただ開瀺されおいたせん。

レヌダヌチャヌト

珟圚
前回倀

アナリスト評䟡

0 人のアナリスト予想に基づく
--
珟圚の評䟡
--
目暙株䟡
--
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

Bio Rad Laboratories Incの泚目ポむント

匷みリスク
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
適正氎準
同瀟の最新のPEは-12.59で、過去3幎間の氎準ず比范しお適正圏にありたす。

Bio Rad Laboratories Inc ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Bio Rad Laboratories Incの䌁業情報

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
䌁業コヌドBIOb
䌁業名Bio Rad Laboratories Inc
最高経営責任者「CEO」Schwartz (Norman D)
りェブサむトhttps://www.bio-rad.com/
KeyAI
î™